NCT03008408 2026-02-11A Phase II, Two-Arm Study of Everolimus and Letrozole, +/- Ribociclib (Lee011) in Patients With Advanced or Recurrent Endometrial CarcinomaM.D. Anderson Cancer CenterPhase 2 Active not recruiting90 enrolled